NCT02912624

Brief Summary

Circulatory shock is a condition of generalized inadequate blood flow through the body, leading to insufficient tissue perfusion and inadequate delivery of oxygen and other nutrients, to the extent that tissues are damaged. Four basic mechanisms of circulatory failure are distinguished, caused by a scale of underlying illnesses: distributive, hypovolemic, obstructive and cardiogenic shock. The last three types are characterized by a low cardiac output and hypovolemia. Distributive shock is characterized by peripheral circulation failure, with a low systemic vascular resistance, a disturbed microcirculation and a high cardiac output. Frequently, these forms overlap. Shock is a common problem in the intensive care unit (ICU) as it affects about one third of the patients. Septic shock appears to be the most common type, followed by cardiogenic and hypovolemic shock. The diagnosis of shock is based on clinical examination with use of well-known circulatory parameters such as blood pressure and heart rate; biochemical parameters such as lactate and direct (semi-)invasive measurement of cardiac output and other variables. Since cardiac output is an important determinant of oxygen delivery, many different methods of measuring cardiac output have been suggested. These methods range from non-invasive to invasive measurements with central lining. The most invasive method, the pulmonary artery catheter (PAC) has long been considered the optimal form of monitoring cardiac output by using thermodilution. However, this technique is associated with adverse events, such as bleeding, and there is no clear evidence of improved outcome. Therefore, numerous other techniques have been proposed, ranging from systems that use the dilution technique but only require central venous and peripheral artery lines; to less invasive tools that estimate cardiac output based on the arterial pressure waveform; and to non-invasive echocardiography. Despite technical advances, much remains unknown about the value of conventionally used hemodynamic parameters for estimating cardiac output. A distinction between macro- and microcirculatory parameters can be made. Commonly used macro-circulatory parameters are heart rate, systolic and diastolic blood pressure, mean arterial pressure and central venous pressure. Lactate is used as a proxy for microcirculatory status. Over the years several other measurements have been suggested to improve insight in the hemodynamics of a certain patient or a group of patients. Skin temperature, capillary refill, mottling score and urinary output are used for hemodynamic assessment of the peripheral circulation and tissue perfusion. Most of these parameters have not been evaluated in a large prospective study and especially a combination of all these parameters has not directly been correlated to cardiac output. More knowledge on the predictive value of all hemodynamic parameters in estimating cardiac output could assist physicians in earlier detection of impaired hemodynamics without the need for invasive or advanced methods. In this study the investigators aim to evaluate all hemodynamic parameters in a large unselected population of critically ill patients and to correlate them to cardiac output. Purpose: The purpose of this study is to create an infrastructure for a registry flexible to incorporate temporarily added specific research questions on the outcome of critically ill patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,090

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 27, 2015

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 21, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 23, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

April 19, 2018

Status Verified

April 1, 2018

Enrollment Period

2.3 years

First QC Date

September 21, 2016

Last Update Submit

April 17, 2018

Conditions

Keywords

Physical ExaminationDiagnostic ImagingUltrasonographyHemodynamicsPatient Outcome AssessmentMortality

Outcome Measures

Primary Outcomes (2)

  • The association of a single or combination of clinical examination findings with cardiac index measured with transthoracic ultrasonography

    Primary outcome of the basic study, answering our diagnostic research question We calculated cardiac index, which was derived from cardiac output. Cardiac output has been measured with the cardiac probe M3S of M4S with default cardiac imaging setting of the General Electric Vivid-S6 mobile ultrasound machine. Two views were obtained: the parasternal long axis (PLAX) and the apical five chamber view (AP5CH). The PLAX was used as the primary view to measure the left ventricular outflow tract (LVOT) diameter. The AP5CH view was used to measure the velocity time integral (VTI) using the pulse wave Doppler signal in the LVOT. Cardiac output was calculated on the ultrasound machine according to the formula: Cardiac output (L/min)=heart rate ∙VTI∙π∙(1/2∙LVOT)\^2 Clinical examination findings have been collected during a one-time physical examination, which is further specified at the study description section.

    Immediately

  • The association of all measured clinical examination findings, biochemical values and hemodynamic variables measured with transthoracic echocardiography with 90-day mortality

    Primary outcome of the basic study, answering our prognostic research question. Clinical examination findings, as well are specified at the study description section. Biochemical values are serum lactate, creatinine and hemoglobine (see study description). Hemodynamic variables are obtained from advanced patient monitoring devices, such as invasive central venous or arterial blood pressures, echocardiographic measurements, etc. Follow-up on all-cause mortality will be obtained from the municipal personal records database. Analysis of mortality will be performed using time-to-event data (patients were censored at 90-days of follow-up).

    90 days

Secondary Outcomes (5)

  • The diagnostic test accuracy of a single or a combination of clinical examination findings to diagnose a low, normal and high cardiac index measured with transthoracic echocardiography

    Immediately

  • The association and diagnostic test accuracy of a single or combination of clinical examination findings with cardiac index in clinically different patient subgroups

    Immediately

  • The association of clinical examination, biochemical and haemodynamic variables and 7- and 30-day mortality

    30 days

  • The association of clinical examination, biochemical and haemodynamic variables that are not visible to caregivers with 90-day mortality

    90 days

  • The association of clinical examination, biochemical and haemodynamic variables with 90-day mortality in clinically different patient subgroups

    90 days

Other Outcomes (28)

  • The association between clinical, biochemical and haemodynamic variables and tissue (muscle) StO2 at the knee measured by near-infrared spectroscopy (NIRS) with the Inspectra StO2 tissue oxygenation monitor

    Immediately

  • The association between clinical, biochemical and haemodynamic variables and tissue (muscle) StO2 at the thenar muscle measured by near-infrared spectroscopy (NIRS) with the Inspectra StO2 tissue oxygenation monitor

    Immediately

  • The association between tissue (muscle) StO2 measured by NIRS and 90-day mortality

    Immediately

  • +25 more other outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will be conducted in the adult Critical Care of the University of Groningen, University Medical Center Groningen, a tertiary teaching hospital in the Northern part of the Netherlands.

You may qualify if:

  • Emergency admission
  • Expected stay \> 24 hours

You may not qualify if:

  • Age \< 18 years
  • Planned admission (either after surgery or for other reasons)
  • Withdrawn or unable to obtain informed consent
  • Continuous resuscitation efforts or mechanical circulatory support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Groningen

Groningen, 9700 RB, Netherlands

Location

Related Publications (6)

  • Hiemstra B, Eck RJ, Koster G, Wetterslev J, Perner A, Pettila V, Snieder H, Hummel YM, Wiersema R, de Smet AMGA, Keus F, van der Horst ICC; SICS Study Group. Clinical examination, critical care ultrasonography and outcomes in the critically ill: cohort profile of the Simple Intensive Care Studies-I. BMJ Open. 2017 Sep 27;7(9):e017170. doi: 10.1136/bmjopen-2017-017170.

    PMID: 28963297BACKGROUND
  • Cox EGM, Wiersema R, Eck RJ, Kaufmann T, Granholm A, Vaara ST, Moller MH, van Bussel BCT, Snieder H, Pleijhuis RG, van der Horst ICC, Keus F. External Validation of Mortality Prediction Models for Critical Illness Reveals Preserved Discrimination but Poor Calibration. Crit Care Med. 2023 Jan 1;51(1):80-90. doi: 10.1097/CCM.0000000000005712. Epub 2022 Nov 15.

  • Cox EGM, Koster G, Baron A, Kaufmann T, Eck RJ, Veenstra TC, Hiemstra B, Wong A, Kwee TC, Tulleken JE, Keus F, Wiersema R, van der Horst ICC; SICS Study Group. Should the ultrasound probe replace your stethoscope? A SICS-I sub-study comparing lung ultrasound and pulmonary auscultation in the critically ill. Crit Care. 2020 Jan 13;24(1):14. doi: 10.1186/s13054-019-2719-8.

  • Koster G, Kaufmann T, Hiemstra B, Wiersema R, Vos ME, Dijkhuizen D, Wong A, Scheeren TWL, Hummel YM, Keus F, van der Horst ICC. Feasibility of cardiac output measurements in critically ill patients by medical students. Ultrasound J. 2020 Jan 8;12(1):1. doi: 10.1186/s13089-020-0152-5.

  • Kaufmann T, Castela Forte J, Hiemstra B, Wiering MA, Grzegorczyk M, Epema AH, van der Horst ICC; SICS Study Group. A Bayesian Network Analysis of the Diagnostic Process and Its Accuracy to Determine How Clinicians Estimate Cardiac Function in Critically Ill Patients: Prospective Observational Cohort Study. JMIR Med Inform. 2019 Oct 30;7(4):e15358. doi: 10.2196/15358.

  • Kaufmann T, Clement RP, Hiemstra B, Vos JJ, Scheeren TWL, Keus F, van der Horst ICC; SICS Study Group. Disagreement in cardiac output measurements between fourth-generation FloTrac and critical care ultrasonography in patients with circulatory shock: a prospective observational study. J Intensive Care. 2019 Apr 11;7:21. doi: 10.1186/s40560-019-0373-5. eCollection 2019.

MeSH Terms

Conditions

Critical IllnessAcute DiseaseShock

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Iwan CC van der Horst, M.D., Ph.D.

    University of Groningen, University Medical Center Groningen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
90 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 21, 2016

First Posted

September 23, 2016

Study Start

March 27, 2015

Primary Completion

July 22, 2017

Study Completion

November 1, 2017

Last Updated

April 19, 2018

Record last verified: 2018-04

Locations